Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
Progressive Myopia Treatment Evaluation for NaturalVue Multifocal Contact Lens Trial
NCT05159765 · View on ClinicalTrials.gov ↗
Study Summary
This is a multi-center, randomized, double-masked clinical trial. All study devices are market approved/cleared in the localities where the study is conducted. Subjects will be randomly assigned to wear NaturalVue Sphere single vision contact lenses (SVCL) or NaturalVue Multifocal (NVMF) soft contact lenses for a total of three years.
Conditions Studied
Interventions
- DEVICE Multifocal contact lenses
- DEVICE Single vision contact lenses
Study Locations (8)
Ontario
- Toronto Eye Care — Toronto
- University of Waterloo School of Optometry — Waterloo
Other
- Hong Kong Polytechnic University — Tsim Sha Tsui
- Myopia Specialist Centre — Singapore
California
- Fig Garden Optometry — Fresno
Illinois
- North Suburban Vision Consultants — Deerfield
New York
- Cooper Eye Care — New York
Texas
- Bellaire Family Eye Care — Bellaire
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 144 participants |
| Start Date | 2022-01-22 |
| Est. Completion | 2026-02 |
| Phase | NA |
Interested in This Trial?
Always speak with your doctor before enrolling in a clinical trial.
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05159765
The ClinicalTrials.gov registry entry for NCT05159765 describes a study currently listed as active not recruiting. It is categorized as NA, which is the standard way researchers label where a study sits along the investigational pathway from early safety work through later efficacy and post-marketing evaluation. The registered enrollment target is 144 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Visioneering Technologies, which has 2 total studies on file at ClinicalTrials.gov, and sponsors are the parties responsible for study design, oversight, and regulatory filings.
The record links to 1 condition, with Myopia appearing as the primary indexed condition, and to 2 interventions — of which Multifocal contact lenses is the first listed. Interventions can include drugs, devices, procedures, behavioral programs, or observational arms, and each is tracked as a separate registry field so that downstream queries can filter accurately. When a trial lists multiple interventions, it usually reflects a multi-arm design or a comparison protocol rather than a single treatment being tested in isolation. The brief summary published in the registry is the clearest source of protocol intent and should be read before drawing conclusions from any sidebar tags.
Geographic footprint matters for practical reasons: NCT05159765 reports 8 study locations spanning 6 distinct geographic areas — top geographies include Ontario, Other, California. A larger site network tends to correlate with broader recruitment capacity, but it does not imply anything about study quality, and site-level enrollment status can diverge from the overall registry status shown above. Every data point on this page comes from the public ClinicalTrials.gov dataset and is reproduced here for reference only; it is not a medical recommendation, an endorsement of the sponsor, or an invitation to enroll. Verify current status, eligibility criteria, and contact details directly at ClinicalTrials.gov, and discuss any participation decision with your own healthcare provider.
Frequently Asked Questions
What is clinical trial NCT05159765 about?
NCT05159765 is a clinical study titled "Progressive Myopia Treatment Evaluation for NaturalVue Multifocal Contact Lens Trial". This is a multi-center, randomized, double-masked clinical trial. All study devices are market approved/cleared in the localities where the study is conducted. Subjects will be randomly assigned to wear NaturalVue Sphere single vision contact lenses (SVCL) or NaturalVue Multifocal (NVMF) soft contac...
What is the current status of trial NCT05159765?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 144 participants. The study started on 2022-01-22. Estimated completion is 2026-02.
What conditions does trial NCT05159765 study?
This clinical trial studies the following conditions: Myopia. These conditions were identified from the trial registry and reflect the primary focus areas of the research.
What interventions are being tested in trial NCT05159765?
The interventions under investigation include: Multifocal contact lenses (DEVICE), Single vision contact lenses (DEVICE). Each intervention is being evaluated for safety and efficacy as part of this clinical study.
Who is sponsoring clinical trial NCT05159765?
This trial is sponsored by Visioneering Technologies, which has 2 total clinical trials registered on ClinicalTrials.gov. The sponsor is responsible for the study's design, funding, and regulatory compliance.
Where is trial NCT05159765 being conducted?
This trial has 8 study locations across California, Illinois, New York, Texas, Ontario. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How Clinical Trials Work
Understand phases 1-4, trial design, randomization, and the informed consent process.
Patient Rights in Clinical Trials
Your rights as a participant: consent, withdrawal, privacy, and who to contact.
Finding the Right Clinical Trial
A practical guide to searching trials, understanding eligibility, and evaluating options.
All Guides
Browse our complete library of clinical trial educational resources.
Read our methodology — how this data is sourced, computed, and verified.